Explore the evolving treatment landscape of chronic myeloid leukemia with asciminib, a promising new TKI showing high ...

Fertility preservation becomes crucial for reproductive-age cancer patients, emphasizing timely intervention and ...

A significant number of patients with ovarian cancer miss preventive salpingectomy opportunities during unrelated surgeries.

Pembrolizumab showed an 89% objective response rate in unresectable desmoplastic melanoma, with a 37% complete response rate.

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

New clinical data reveals promising efficacy of VS-7375, a KRAS G12D inhibitor, in advanced lung cancer, highlighting its ...

During a live event, Misty D. Shields, MD, PhD, discussed using G-CSF and trilaciclib to mitigate chemotherapy-induced ...

New research reveals that many patients with low-risk thyroid cancer can safely skip postoperative radioiodine ablation, ...

New findings reveal promising efficacy of irpagratinib and atezolizumab in treating advanced hepatocellular carcinoma with ...

A digital app significantly enhances the quality of life for caregivers of stem cell transplant patients, reducing stress and ...

A groundbreaking study enhances stem cell transplant access for diverse patients, improving outcomes with mismatched donors ...

New trial results reveal that pembrolizumab and enfortumab vedotin significantly enhance survival rates for muscle-invasive ...